Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone Vaginal Gel for Prevention of Preterm Delivery
NCT00086177Phase 3Completed
- Sponsor
- Juniper Pharmaceuticals, Inc.
- Start
- Apr 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preterm birth comparing Progesterone Gel with Placebo Gel (2 arms). Primary endpoint: Frequency of delivery <=32 weeks. Started Apr 2004; status: completed.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT00086177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086177.